Dr Richard Turkington MB BCh BAO BSc MRCP PhD
Senior Council Member
Clinical Senior Lecturer in Medical Oncology
I am a Clinical Senior Lecturer in Medical Oncology at the Centre for Cancer Research and Cell Biology, Queen’s University Belfast and an Honorary Consultant at the Northern Ireland Cancer Centre with an interest in oesophago-gastric cancer. Having graduated in medicine from Queen’s University Belfast I began specialty training in Medical Oncology in 2005.
In 2007 I was awarded a Cancer Research UK Bobby Moore Clinical Research Fellowship to pursue a PhD in novel drug target discovery in colo-rectal cancer under the supervision of Professor Patrick Johnston. Following completion of my Phd I was appointed as an Academic Clinical Lecturer in the field of oesophago-gastric cancer and in 2013 became a Visiting Research Fellow at the Hutchison/MRC Cancer Unit, University of Cambridge, under the supervision of Professor Rebecca Fitzgerald.
My work has been published in high impact journals and in 2014 I received the American Society of Clinical Oncology Merit Award. My principle research interests include oesophago-gastric cancer and the analysis of genomic datasets for the discovery of biomarkers and mechanisms of resistance to chemotherapeutic agents. These discoveries are being translated into clinical advances through the implementation of biomarker-led clinical trials. As part of the oesophago-gastric cancer team at Queen’s University Belfast I seek to transform the care of oesophago-gastric patients through the integration of laboratory discoveries, translational science and clinical research.
3D mammosphere culture of breast epithelial cell line MCF10A.
Courtesy of Dr. Emer Bourke, NUI Galway
Phospho-Akt expression and localisation
Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.
Metaphase chromosome spread of Jurkat T-lymphoma cells
Apoptosis assessment of SKMES-1 lung cancer cells
Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).
Mitotic Chronic Myelogenous Leukaemia K562 Cells
Cell to Cell Tweeting
Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)
Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.
Confocal Microscopy Analysis
Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).
We have a number of membership categories available. Find out which membership suits you.
Due to COVID restrictions we have yet to confirm the dates for 57th Annual Conference.
Please check back here later in 2020 to check for updates.
IACR Public Engagement
Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?
The Irish Association for Cancer Research will support a limited number of Educational Grants that will be made available to postgraduate PhD researchers who have been affected by the Covid-19 pandemic. We acknowledge that many of our members have been significantly impacted by the recent pandemic that may have affected their ability to continue and/or complete research projects.
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven